Advantage Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Advantage Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-400	Closed	-$21K	–	1098
2017 Q3	$21K	Hold	400	–	–	0.01%	543
2017 Q2	$23K	Hold	400	–	–	0.01%	541
2017 Q1	$18K	Hold	400	–	–	0.01%	571
2016 Q4	$21K	Hold	400	–	–	0.01%	501
2016 Q3	$18K	Hold	400	–	–	0.01%	521
2016 Q2	$15K	Hold	400	–	–	0.01%	523
2016 Q1	$16K	Buy	+400	New	+$16.5K	0.01%	495

Other funds holding SYNH

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Advantage Investment Management's SYNH Position: Q4 2017 in Review

Advantage Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2017, closing a stake of 400 shares — an estimated $21K sold.

Advantage Investment Management first reported a position in SYNH in Q1 2016 and held it in 7 quarters. The position peaked at $23K in Q2 2017. 194 funds tracked by Wall St. Rank hold SYNH as of Q4 2017.

Advantage Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2017 after selling out during the quarter.
Advantage Investment Management sold 400 Syneos Health, Inc. Class A Common Stock shares in Q4 2017, an estimated $21K.
Advantage Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 7 quarters.
Advantage Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $23K in Q2 2017.
194 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2017.

Based on Advantage Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.